Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study. Anthony MS, Aroda VR, Parlett LE, Djebarri L, et al. Diabetes Care 2024;47:712-719.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anthony MS, Aroda VR, Parlett LE, Djebarri L, et al. Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study. Diabetes Care 2024;47:712-719.
PMID: 38363873